AbbVie Says Recent Antitrust Ruling Irrelevant In Humira Case
AbbVie Inc. has told an Illinois federal court that a recent ruling in a case involving speech recognition technology is not relevant whatsoever to Humira buyers' allegations that the pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article